Background. The Swedish adjustable gastric band (SAGB) is used to treat morbid obesity. However, no quantitative data are available describing the follow-up of these patients with respect to the frequency and the complication rate of inflating and deflating the adjustable system. Methods. We prospectively investigated 207 morbidly obese patients. All patients completed 12 months of follow-up and were seen in intervals of 1 to 3 months on an outpatient basis. Results. A total of 207 patients had 1692 consultations (8.3 ± 2.4 consultations per patient per year) [mean ± SD], 920 port-a-catch punctions (4.6 ± 2.0), 820 inflations (4.1 ± 1.6), and 100 deflations (1.4 ± 0.6). Complications related to the port-a-catch (n = 6, 2.9% of all patients) were 1 leakage of the tube (0.5%), 2 disconnections of the connecting tube (1.0%), and 3 reimplantations of the port-a-cath as a result of discomfort (1.4%). Complications related to the SAGB (n = 10, 4.8%) were 6 leakages of the band (2.9%), 2 penetrations (1.0%), 1 intraoperative perforation of the esophagus (0.5%), and 1 dystopically implanted SAGB (0.5%). Additionally, 9 minor early postoperative wound infections (4.3%) were recorded. Conclusions. Follow-up can be safely performed on an outpatient basis after implantation of a SAGB without infectious and other minor complications directly linked to the filling procedure. (Surgery 2000;127:484–8)
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Surgery
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- NHANES III reference manuals and reports [CD-ROM].: US Department of Health and Human Services, Public Health Service, CDC, Hyattsville, Maryland1996
- Overweight and obesity in the United States: prevalence and trends, 1960–1994.Int J Obes Relat Metab Disord. 1998; 22: 39-47
- Physical activity and health: a report of the surgeon general.: US Department of Health and Human Services, Public Health Service, CDC, National Center for Chronic Disease Prevention and Health Promotion, Atlanta1996
- Treatment of obesity by moderate and severe caloric restriction. Results of clinical research trials.Ann Intern Med. 1993; 119: 688-693
- A meta-analysis of the past 25 years of weight loss research using diet, exercise, or diet plus exercise intervention.Int J Obes Relat Metab Disord. 1997; 21: 941-947
- Randomized placebo-controlled trial of Orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group.Lancet. 1998; 352: 167-172
- Swedish adjustable gastric band (SAGB)-distal gastric bypass: a new variant of an old technique in the treatment of superobesity and failed band restriction.Obes Surg. 1999; 2: 171-176
- The rationale and results of gastroplasty/distal gastric bypass.Obes Surg. 1992; 2: 61-68
- Silicone gastric banding: a simple and effective operation for morbid obesity.Contemp Surg. 1986; 28: 13-18
- Ballongband vid behandling av massiv övervikt. (Balloon band for the treatment of massive obesity).Svensk Kirurgi. 1985; 43: 106-109
- Laparoscopic adjustable gastric banding: A prospective 4-year follow-up study.Obes Surg. 1999; 9: 183-187
- Prospective investigation of complications and weight loss with an adjustable gastric banding device for treatment of morbid obesity.J Gastrointest Surg. 1998; 2: 102-108
Accepted: October 5, 1999
*Reprint requests: F. F. Horber, MD, Hirslanden Clinic, Witellikerstr 40, CH-8008 Zürich, Switzerland.
© 2000 Mosby, Inc. Published by Elsevier Inc. All rights reserved.